MicroRNAs of microglia: Wrestling with central nervous system disease [PDF]
Microglia serve as brain-resident myeloid cells that affect cerebral development, ischemia, neurodegeneration, and neuro-viral infection. MicroRNAs play a key role in central nervous system disease through post-transcriptional regulation.
Xiao-Hua Wang, Tian-Long Wang
doaj +3 more sources
B cells in central nervous system disease: diversity, locations and pathophysiology. [PDF]
B cells represent a relatively minor cell population within both the healthy and diseased central nervous system (CNS), yet they can have profound effects.
Jain RW, Yong VW.
europepmc +2 more sources
Bioavailable central nervous system disease-modifying therapies for multiple sclerosis [PDF]
Disease-modifying therapies for relapsing multiple sclerosis reduce relapse rates by suppressing peripheral immune cells but have limited efficacy in progressive forms of the disease where cells in the central nervous system play a critical role.
Hans-Peter Hartung+8 more
doaj +2 more sources
Air Pollution and Central Nervous System Disease: A Review of the Impact of Fine Particulate Matter on Neurological Disorders. [PDF]
Background: It is widely known that the harmful effects of fine dust can cause various diseases. Research on the correlation between fine dust and health has been mainly focused on lung and cardiovascular diseases.
Kim H, Kim WH, Kim YY, Park HY.
europepmc +2 more sources
Immune-Mediated Central Nervous System Disease-Current Knowledge and Recommendations. [PDF]
&NA; Immune‐mediated inflammation is responsible for about 25% of central nervous system disease in dogs. The disease can affect all ages and breeds, but young to middle‐aged small breed dogs are over‐represented for most forms.
Vitale S, Foss K.
europepmc +2 more sources
Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network [PDF]
In acute lymphoblastic leukemia, flow cytometry detects more accurately leukemic cells in patients' cerebrospinal fluid compared to conventional cytology.
Maria Ilaria Del Principe+24 more
doaj +2 more sources
Disulfidptosis: a new target for central nervous system disease therapy [PDF]
Disulfidptosis is a pathologic process that occurs under conditions of NADPH deficiency and excess disulfide bonds in cells that express high levels of SLC7A11.
Jing Chang+8 more
doaj +2 more sources
Gait Rehabilitation Device in Central Nervous System Disease: A Review
Central nervous system diseases cause the gait disorder. Early rehabilitation of a patient with central nervous system disease is shown to be benefit. However, early gait training is difficult because of muscular weakness and those elderly patients who ...
Kazuya Kubo+3 more
doaj +2 more sources
Paraneoplastic Diseases of the Central Nervous System [PDF]
Paraneoplastic neurological syndromes are nonmetastatic complications of malignancy secondary to immune-mediated neuronal dysfunction or death. Pathogenesis may occur from cell surface binding of antineuronal antibodies leading to dysfunction of the target protein, or from antibodies binding against intracellular antigens which ultimately leads to cell
Jonathan R. Galli+2 more
openaire +3 more sources
Tocilizumab, a humanized anti-IL-6 receptor monoclonal antibody, showed its therapeutic efficacy on neuromyelitis optica spectrum disorder (NMOSD).
Ye Liu+12 more
doaj +1 more source